Verapamil Hydrochloride Patent Expiration

Verapamil Hydrochloride is Used for treating cardiovascular disease through the administration of a calcium blocking vasodilator. It was first introduced by Mt Adams Technologies Llc in its drug Isoptin on Approved Prior to Jan 1, 1982. Other drugs containing Verapamil Hydrochloride are Covera-Hs, Verapamil Hydrochloride, Calan, Calan Sr, Verelan Pm, Verelan. 41 different companies have introduced drugs containing Verapamil Hydrochloride.


Verapamil Hydrochloride Patents

Given below is the list of patents protecting Verapamil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Covera-hs US6096339 Dosage form, process of making and using same Apr 04, 2017

(Expired)

Pfizer



Verapamil Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Verapamil Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Verapamil Hydrochloride. The first generic version for Verapamil Hydrochloride was by Luitpold Pharmaceuticals Inc and was approved on Nov 12, 1985. And the latest generic version is by Fresenius Kabi Usa Llc and was approved on Apr 23, 2024.

Given below is the list of companies who have filed for Verapamil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.